Skip to content

Effectiveness of outpatient rehabilitation treatment using the WelWalk for chronic cerebrovascular disease patients

Preliminary study on the effectiveness of gait training using the Welwalk for chronic cerebrovascular disease patients in outpatient rehabilitation - PSEGTUWCCDPOR

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs042230079
Enrollment
10
Registered
2023-09-07
Start date
2024-01-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Carry out gait training using WelWalk for 60 minutes a day, twice a week for 10 weeks in addition to conventional exercise therapy

Sponsors

Otaka Yohei
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Participants who gave written consent to participate in this study from themselves or their proxy consents 2.Stroke participants participate with outpatient treatment 2 or more times at Fujita Health University Nanakuri Memorial Hospital 3.Participants who can gait exercise (regardless of the use of a walking aid) 4.Participants who require assistance with walking or whose walking speed is less than 0.8 km/h 5.Participants body weight >= 35 kg and 140 cm and < 190 cm 7.Participants are more than 40 years old

Exclusion criteria

Exclusion criteria: 1.Participants with uncontrolled hypertension or hypotension 2.Participants with uncontrolled cardiac or respiratory dysfunction 3.Participants with pacemakers 4.Participants with susceptible fractures of the legs or spine (such as severe osteoporosis) 5.Participants with ectopic ossification of the lower extremities leading to limited range of motion 6.Pregnant and possibly pregnant participants 7.Participants who have an infection and require isolation 8.Participants scheduled for antispasticity therapy with botulinum toxin preparations to the lower extremities during the study period 9.When practicing wearing robot legs, participants who have difficulty wearing robot legs due to excessive or deformed lower limbs or pressure sores 10.Other participants judged inappropriate by the attending physician, investigator, subinvestigator, or subinvestigator

Design outcomes

Primary

MeasureTime frame
Change in walking speed and Life-Space Assessment before and after intervention

Secondary

MeasureTime frame
1.Walking speed 2.Spatio-temporal parameters for walking 3.Muscle strength of Quadriceps 4.Stroke Impairment Assessment Set-motor score(lower limb), sensory(lower limb), trunk function, muscle tone(lower limb) 5.Barthel index(BI) 6.Functional Independence Measure(FIM) 7.Vitality Index 8.Life-Space Assessment 9.Gait Ability Assessment for hemiplegics(GAA) 10.Cognitive-related Behavioral Assessment(CBA) 11.Frenchay Activities Index(FAI) 12.SF-8 13.Subjective evaluation before and after Welwalk intervention(Global rating of change scales) 14.Retrospective investigation of assessment results recorded in past care records 15.Record of walking practice using Welwalk

Contacts

Public ContactTetsuya Tsunoda

Fujita Health University Nanakuri Memorial Hospital

ttvista0914@yahoo.co.jp+81-59-252-1555

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026